Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria. 1998

L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
Center Francais des Porphyries, INSERM, Hopital Louis Mourier, Colombes, France.

Erythropoietic protoporphyria is a hereditary disorder of porphyrin metabolism caused by mutations in the ferrochelatase gene. Ferrochelatase catalyzes the chelation of ferrous iron into protoporphyrin IX to form heme. Mutation analysis was performed in four Spanish erythropoietic protoporphyria families resulting in the identification of four different mutations in the ferrochelatase gene. Two of them were novel mutations, a missense mutation (1157 A-->C, H386P) and a frameshift mutation (843delC) found in two Spanish families, respectively. The third and the forth Spanish patients carried already published ferrochelatase gene mutations, a nonsense mutation (343C-->T, R115X) and a missense mutation (557T-->C, I186T), respectively. The newly described frameshift mutation (843delC) predicted formation of an abrupt mRNA. The deleterious effect of His386 to Pro substitution as a result of mutation 1157 A-->C on the ferrochelatase activity was investigated by expressing the mutant ferrochelatase in Escherichia coli. The mutant ferrochelatase exhibited only 0.8% of the wild-type ferrochelatase activity. Prediction of the secondary structure of ferrochelatase suggested that the H386P mutation disrupted the original alpha-helical structure by way of introducing a turn, a rather drastic structural change of the enzyme sufficient to cause activity loss.

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005260 Female Females
D005294 Ferrochelatase A mitochondrial enzyme found in a wide variety of cells and tissues. It is the final enzyme in the 8-enzyme biosynthetic pathway of HEME. Ferrochelatase catalyzes ferrous insertion into protoporphyrin IX to form protoheme or heme. Deficiency in this enzyme results in ERYTHROPOIETIC PROTOPORPHYRIA. Heme Synthetase,Porphyrin-Metal Chelatase,Protoheme Ferro-Lyase,Zinc Chelatase,Chelatase, Porphyrin-Metal,Chelatase, Zinc,Ferro-Lyase, Protoheme,Porphyrin Metal Chelatase,Protoheme Ferro Lyase,Synthetase, Heme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013030 Spain Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. Balearic Islands,Canary Islands
D016368 Frameshift Mutation A type of mutation in which a number of NUCLEOTIDES deleted from or inserted into a protein coding sequence is not divisible by three, thereby causing an alteration in the READING FRAMES of the entire coding sequence downstream of the mutation. These mutations may be induced by certain types of MUTAGENS or may occur spontaneously. Mutation, Frameshift,Frame Shift Mutation,Out-of-Frame Deletion,Out-of-Frame Insertion,Out-of-Frame Mutation,Deletion, Out-of-Frame,Deletions, Out-of-Frame,Frame Shift Mutations,Frameshift Mutations,Insertion, Out-of-Frame,Insertions, Out-of-Frame,Mutation, Frame Shift,Mutation, Out-of-Frame,Mutations, Frame Shift,Mutations, Frameshift,Mutations, Out-of-Frame,Out of Frame Deletion,Out of Frame Insertion,Out of Frame Mutation,Out-of-Frame Deletions,Out-of-Frame Insertions,Out-of-Frame Mutations
D017121 Porphyria, Hepatoerythropoietic An autosomal recessive cutaneous porphyria that is due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in both the LIVER and the BONE MARROW. Similar to PORPHYRIA CUTANEA TARDA, this disorder is caused by defects in the fifth enzyme in the 8-enzyme biosynthetic pathway of HEME, but is a homozygous enzyme deficiency with less than 10% of the normal enzyme activity. Cutaneous lesions are severe and mutilating. Hepatoerythropoietic Porphyria,Porphyria, Erythrohepatic,Erythrohepatic Porphyria,Erythrohepatic Porphyrias,Hepatoerythropoietic Porphyrias,Porphyrias, Erythrohepatic,Porphyrias, Hepatoerythropoietic

Related Publications

L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
February 1996, The Journal of investigative dermatology,
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
November 1997, The Journal of investigative dermatology,
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
April 2007, Molecular genetics and metabolism,
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
December 1991, Biochemical and biophysical research communications,
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
February 2002, Cellular and molecular biology (Noisy-le-Grand, France),
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
May 1998, Blood,
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
July 1999, The Journal of investigative dermatology,
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
January 1994, Biochimica et biophysica acta,
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
July 1996, British journal of haematology,
L Gouya, and X Schneider-Yin, and U Rüfenacht, and C Herrero, and M Lecha, and J M Mascaro, and H Puy, and J C Deybach, and E I Minder
April 1995, Journal of bioenergetics and biomembranes,
Copied contents to your clipboard!